Inhibition of Toll-Like Receptor 4 Signaling Mitigates Microvascular Loss but Not Fibrosis in a Model of Ischemic Acute Kidney Injury

The development of chronic kidney disease (CKD) following an episode of acute kidney injury (AKI) is an increasingly recognized clinical problem. Inhibition of toll-like receptor 4 (TLR4) protects renal function in animal models of AKI and has become a viable therapeutic strategy in AKI. However, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagher, Pierre C., Hato, Takashi, Mang, Henry E., Plotkin, Zoya, Richardson, Quentin V., Massad, Michael, Mai, Erik, Kuehl, Sarah E., Graham, Paige, Kumar, Rakesh, Sutton, Timothy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881473/
https://www.ncbi.nlm.nih.gov/pubmed/27136544
http://dx.doi.org/10.3390/ijms17050647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881473/
https://www.ncbi.nlm.nih.gov/pubmed/27136544
http://dx.doi.org/10.3390/ijms17050647

Ejemplares similares